# An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

> **NCT01277328** · — · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 95 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01277328
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 95 (ACTUAL)
- **Why stopped:** Contract terminated with Site Management Organization
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01277328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01277328, "An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01277328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*